Skip to main content

Table 1 Correlation between serum exosomal miR-184 expression levels in patients with NSCLC and their clinicopathological characteristics. (* p < 0.05)

From: Elevated exosome-derived miRNAs predict osimertinib resistance in non-small cell lung cancer

Clinicopathological parameters Number of patients(%) Exosomal miR-184
Low High P
Age(years), Median     0.777
 < 60 33 15 18  
 ≥ 60 31 13 18  
Gender     0.899
 Male 28 12 16  
 Female 36 16 20  
Smoking history     0.353
 Never smoking 49 23 26  
 Now/once smoking 15 5 10  
ECOG Score     0.226
 0–1 53 25 28  
 ≥ 2 11 3 8  
Primary tumor     0.705
 ≤ 4 cm 19 9 10  
 > 4 cm 45 19 26  
TNM     0.317
 I–IVA 25 9 16  
 IVB 39 19 20  
PLT     0.411
 Low(≤ 146) 13 7 6  
 High(> 146) 51 21 30  
LDH     0.018*
 Low(≤ 199) 29 8 21  
 High(> 199) 35 20 15  
CEA     0.129
 Low(≤ 8.605) 25 8 17  
 High(> 8.605) 39 20 19  
Distant metastasis     0.164
 No 17 5 12  
 Yes 47 23 24  
Contralateral lung metastasis     0.069
 No 24 7 17  
 Yes 40 21 19  
Pleura metastasis     0.825
 No 33 14 19  
 Yes 31 14 17  
Bone metastasis     
 No 23 9 14  
 Yes 41 19 22  
Brain metastasis     
 No 36 14 22  
 Yes 28 14 14